Skip to content
10-Q

Quarterly Report

IMMUCELL CORP /DE/ ICCC

0001437749-25-034817

← back to feed
Filed
Nov 13, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Oct 31, 2025 9.05M sh
Shares Diluted Q3 2025 · Sep 30, 2025 9.05M sh
Shares Diluted Q3 2025 · Sep 30, 2025 9.02M sh
Shares Diluted Q3 2025 · Sep 30, 2024 8.16M sh
Shares Diluted Q3 2025 · Sep 30, 2024 7.91M sh
Capex Q3 2025 · Sep 30, 2025 $1.08M
Capex Q3 2025 · Sep 30, 2024 $269.51K
Operating Cash Flow Q3 2025 · Sep 30, 2025 $1.99M
Operating Cash Flow Q3 2025 · Sep 30, 2024 $360.95K
Long Term Debt Q3 2025 · Sep 30, 2025 $7.9M
Long Term Debt Q3 2025 · Dec 31, 2024 $9.04M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $3.89M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $3.76M
Stockholders Equity Q3 2025 · Sep 30, 2025 $29.8M
Stockholders Equity Q3 2025 · Jun 30, 2025 $29.87M
Stockholders Equity Q3 2025 · Dec 31, 2024 $27.52M
Stockholders Equity Q3 2025 · Sep 30, 2024 $26.41M
Stockholders Equity Q3 2025 · Jun 30, 2024 $23.46M
Stockholders Equity Q3 2025 · Dec 31, 2023 $24.99M
Current Liabilities Q3 2025 · Sep 30, 2025 $4M
Current Liabilities Q3 2025 · Dec 31, 2024 $4.41M
Total Liabilities Q3 2025 · Sep 30, 2025 $15.93M
Total Liabilities Q3 2025 · Dec 31, 2024 $17.58M
Current Assets Q3 2025 · Sep 30, 2025 $16.83M
Current Assets Q3 2025 · Dec 31, 2024 $15.04M
Total Assets Q3 2025 · Sep 30, 2025 $45.73M
Total Assets Q3 2025 · Dec 31, 2024 $45.1M
Total Assets Q3 2025 · Sep 30, 2024 $44.45M
Total Assets Q3 2025 · Dec 31, 2023 $43.81M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.02
Eps Diluted Q3 2025 · Sep 30, 2025 $0.20
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.09
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.34
Eps Basic Q3 2025 · Sep 30, 2025 −$0.02
Eps Basic Q3 2025 · Sep 30, 2025 $0.20
Eps Basic Q3 2025 · Sep 30, 2024 −$0.09
Eps Basic Q3 2025 · Sep 30, 2024 −$0.34
Sga Expense Q3 2025 · Sep 30, 2025 $729.42K
Sga Expense Q3 2025 · Sep 30, 2025 $2.07M
Sga Expense Q3 2025 · Dec 31, 2024 $2.22M
Sga Expense Q3 2025 · Sep 30, 2024 $528.27K
Sga Expense Q3 2025 · Sep 30, 2024 $1.66M
Sga Expense restated Q3 2025 · Sep 30, 2023 $2.13M
Rd Expense Q3 2025 · Sep 30, 2025 $694.31K
Rd Expense Q3 2025 · Sep 30, 2025 $2.28M
Rd Expense Q3 2025 · Dec 31, 2024 $3.9M
Rd Expense Q3 2025 · Sep 30, 2024 $786.14K
Rd Expense Q3 2025 · Sep 30, 2024 $3.08M
Rd Expense restated Q3 2025 · Sep 30, 2023 $4.39M
Net Income Q3 2025 · Sep 30, 2025 −$139.75K
Net Income Q3 2025 · Sep 30, 2025 $1.81M
Net Income Q3 2025 · Sep 30, 2024 −$701.69K
Net Income Q3 2025 · Sep 30, 2024 −$2.67M
Operating Income Q3 2025 · Sep 30, 2025 $20.08K
Operating Income Q3 2025 · Sep 30, 2025 $1.71M
Operating Income Q3 2025 · Dec 31, 2024 −$1.64M
Operating Income Q3 2025 · Sep 30, 2024 −$574.89K
Operating Income Q3 2025 · Sep 30, 2024 −$2.26M
Operating Income restated Q3 2025 · Sep 30, 2023 −$5.75M
Gross Profit Q3 2025 · Sep 30, 2025 $2.36M
Gross Profit Q3 2025 · Sep 30, 2025 $8.53M
Gross Profit Q3 2025 · Dec 31, 2024 $7.94M
Gross Profit Q3 2025 · Sep 30, 2024 $1.58M
Gross Profit Q3 2025 · Sep 30, 2024 $5.11M
Gross Profit restated Q3 2025 · Sep 30, 2023 $3.87M
Cost Of Revenue Q3 2025 · Sep 30, 2025 $3.14M
Cost Of Revenue Q3 2025 · Sep 30, 2025 $11.48M
Cost Of Revenue Q3 2025 · Dec 31, 2024 $18.55M
Cost Of Revenue Q3 2025 · Sep 30, 2024 $4.43M
Cost Of Revenue Q3 2025 · Sep 30, 2024 $13.63M
Cost Of Revenue Q3 2025 · Sep 30, 2023 $13.6M
Revenue Q3 2025 · Sep 30, 2025 $5.51M
Revenue Q3 2025 · Sep 30, 2025 $20.02M
Revenue Q3 2025 · Dec 31, 2024 $26.49M
Revenue Q3 2025 · Sep 30, 2024 $6.01M
Revenue Q3 2025 · Sep 30, 2024 $18.74M
Revenue restated Q3 2025 · Sep 30, 2023 $17.47M
Stock Issued Q3 2025 · Apr 30, 2021 4.55M sh